Stay updated on Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the SAPPHIRE Phase 3 study is displayed with its trial details, participant criteria, study locations, outcome measures, and related documents and links.
    Difference
    100%
    Check dated 2026-11-08T13:40:11.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:58:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH announcement says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:00:50.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T15:15:11.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T15:09:42.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an error screen. The prior study details and related sections are no longer visible.
    Difference
    16%
    Check dated 2026-09-20T22:35:28.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.